DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Sternberg CN. et al.
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update.

Eur J Cancer 2013;
49: 1287-1296

Download Bibliographical Data

Access:
Access: